Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.45
Delayed Data
As of Dec 02
 +0.14 / +0.91%
Today’s Change
13.77
Today|||52-Week Range
119.87
-84.80%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Papa Joseph C
Chairman & Chief Executive Officer
Buy6/10/2016202,000$24.48$4.9M-36.00%
Schiller Howard Bradley
Chairman & Chief Executive Officer
Sale2/18/201651,846$91.45$4.7M-83.58%
Kellen Ari
Chairman
Sale1/26/20163,317$88.98$295.1K-84.33%
Schiller Howard Bradley
Chairman & Chief Executive Officer
Sale2/18/20162,245$91.45$205.3K-83.58%
Karabelas Argeris N
Director
Buy8/11/20164,000$24.65$98.6K-36.91%
Ross Thomas W Sr
Director
Buy6/13/20164,000$24.40$97.6K-35.03%
Robertson Russel C
Director
Gift9/30/20161,376$24.55$33.8K-37.07%
Rosiello Robert L
Chief Financial Officer & Executive Vice President
Sale8/03/20161,338$23.54$31.5K-30.90%
Wechsler Amy B
Director
Gift9/30/20161,018$24.55$25.0K-37.07%
Ingram Robert Alexander
Director
Gift6/30/20161,080$20.14$21.8K-23.29%
Page of 5